Product image of Moxtenz (Moxonidine) supplied by GNH India

Moxtenz

Active Ingredient:
Moxonidine
Origin:
EU

Moxtenz (Moxonidine)

Moxonidine, the active ingredient in Moxtenz, is an imidazoline receptor agonist presented as an oral tablet for oral use. It is used to treat hypertension in adult patients, helping to lower elevated blood pressure levels.
GNH India supplies Moxtenz as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Farmak International Sp. Z O.O.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Moxonidine acts on the central sympathetic nervous system to manage high blood pressure.

  • Hypertension: lowers systolic and diastolic blood pressure in patients with primary hypertension.
  • Essential hypertension: improves overall blood pressure control when lifestyle measures are insufficient.
  • Resistant hypertension: provides an additional therapeutic option for patients whose blood pressure remains uncontrolled despite other antihypertensives.

How It Works

  • Moxonidine selectively stimulates imidazoline I1 receptors in the rostral ventrolateral medulla, which reduces central sympathetic outflow. The decreased sympathetic activity leads to reduced peripheral vascular resistance and cardiac output, resulting in a gradual decline in arterial blood pressure.

Side Effects

Moxonidine may cause a range of adverse reactions, most of which are mild and reversible.

Common Side Effects

  • Dry mouth: sensation of reduced salivation.
  • Fatigue: feeling of tiredness or lack of energy.
  • Dizziness: light‑headedness, especially when standing quickly.
  • Headache: mild to moderate cranial pain.
  • Nausea: feeling of stomach upset.
  • Constipation: reduced bowel movements.

Serious or Rare Side Effects

  • Severe hypotension: markedly low blood pressure requiring medical attention.
  • Bradycardia: unusually slow heart rate.
  • Hepatic dysfunction: abnormal liver enzyme elevations.
  • Allergic reactions: rash, itching, or swelling.
  • Syncope: sudden loss of consciousness.
  • Electrolyte imbalance: abnormal potassium or sodium levels.

Precautions & Warnings

Before initiating therapy with Moxonidine, certain safety considerations should be observed.

  • Renal impairment: adjust use in patients with reduced kidney function.
  • Hepatic disease: monitor liver function tests regularly.
  • Cardiovascular disease: use cautiously in patients with heart failure or recent myocardial infarction.
  • Pregnancy: avoid unless clearly needed; discuss risks with a healthcare professional.
  • Breastfeeding: consider potential exposure to the infant; consult a physician.
  • Store at ambient temperature: keep below 25°C, retain in original packaging, protect from moisture and direct sunlight.

Avoid Interactions

Moxonidine can interact with other medicines, altering its effectiveness or safety profile.

Major Interactions (Avoid)

  • Clonidine: additive hypotensive effect may cause severe low blood pressure.
  • Beta‑blockers: combined use can lead to excessive bradycardia.

Moderate Interactions (Monitor Closely):\n- Diuretics: may enhance antihypertensive response; monitor electrolytes.

  • ACE inhibitors or ARBs: potential for additive blood pressure reduction.
  • NSAIDs: may blunt antihypertensive effect; watch blood pressure trends.

Frequently Asked Questions

Moxtenz contains the active ingredient Moxonidine and is prescribed to lower high blood pressure in adults. It belongs to the class of imidazoline receptor agonists and is indicated for the treatment of hypertension, including cases that are not adequately controlled by other medications.

Moxonidine selectively activates imidazoline I1 receptors in the brainstem, which reduces the activity of the sympathetic nervous system. This leads to decreased peripheral vascular resistance and lower cardiac output, ultimately resulting in a reduction of arterial blood pressure.

The dosage of Moxtenz is individualized by a qualified prescriber based on the patient’s clinical condition, response to therapy, and any comorbidities. The prescribing physician determines the appropriate strength, frequency, and duration of treatment.

The safety of Moxonidine in pregnancy or while breastfeeding has not been definitively established. It should only be used if the potential benefit justifies the potential risk to the fetus or infant, and this decision must be made by a healthcare professional.

To request Moxtenz, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Compared with traditional centrally acting agents such as clonidine, Moxonidine has a more selective affinity for imidazoline I1 receptors, which may result in fewer sedative and dry‑mouth side effects. Its efficacy in lowering blood pressure is comparable, but the side‑effect profile can be more favorable for some patients.

Moxtenz should be stored at ambient temperature, preferably below 25 °C. Keep the tablets in the original container, protect them from moisture, heat, and direct sunlight, and ensure they are out of reach of children.

Moxtenz is taken orally, usually with or without food, as directed by the prescribing clinician. Swallow the tablet whole with a glass of water; do not crush, chew, or split the tablet unless specifically instructed by a healthcare professional.

The most serious adverse events include severe hypotension, bradycardia, and rare cases of hepatic dysfunction. Patients should be monitored for symptoms such as dizziness, fainting, unusually slow heart rate, or signs of liver injury, and seek medical attention promptly if they occur.

Moxtenz is contraindicated in patients with known hypersensitivity to Moxonidine or any excipients in the formulation. Caution is advised, and use should be avoided, in individuals with severe renal or hepatic impairment, uncontrolled heart failure, or those taking other potent centrally acting antihypertensives without medical supervision.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Moxonidine

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT